Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

FDA Regulatory Approval Updates

Posted by author-avatar
0
Test Logo Transparent

On October 17, 2025, Amgen and AstraZeneca announced that the FDA has approved an additional indication for TEZSPIRE (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients aged 12 years and older….
By: Goodwin

Newer
California Governor Vetoes Employment Automated Decision Systems Bill
Back to list
Older Tunney Act Tussle: State AGs launch challenge to DOJ merger settlement

Leave a Reply

Your email address will not be published. Required fields are marked *